Akums Drugs and Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹515.50(4.84%)April 10, 2026 15:59:39 PM IST
- NSE
- BSE
- Vol : 247.22 K (NSE + BSE)Last 20 day avg : 182.56 K
Akums Drugs and Pharmaceuticals is trading 4.84% upper at Rs 515.50 as compared to its last closing price. Akums Drugs and Pharmaceuticals has been trading in the price range of 518.50 & 495.80. Akums Drugs and Pharmaceuticals has given 8.46% in this year & -0.95% in the last 5 days. There are 3 analysts who have initiated coverage on Akums Drugs and Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 66.32 Crores in its last quarter.Listed peers of Akums Drugs and Pharmaceuticals include Torrent Pharmaceuticals (1.77%), Dr Reddy's Laboratories (1.62%), Sun Pharmaceutical Industries (-3.65%).The Mutual Fund holding in Akums Drugs and Pharmaceuticals was at 10.95% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Akums Drugs and Pharmaceuticals was at 1.38% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 10, 2026, 11:29 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 4,165.80 | 1.77 | 1,41,002.88 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bearish | 1,232.00 | 1.62 | 1,03,041.66 | 18.63 | 3.14 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bearish | 1,654.70 | -3.65 | 3,97,008.60 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Moderately Bearish | 1,229.60 | 0.44 | 99,373.66 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,105.00 | 2.47 | 1,62,000.59 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE09XN01023
- BSE Code544222
- NSE CodeAKUMS
Akums Drugs and Pharmaceuticals is trading at 515.50 as on Fri Apr 10 2026 10:29:39. This is 4.84% upper as compared to its previous closing price of 491.70.
The market capitalization of Akums Drugs and Pharmaceuticals is 8113.66 Cr as on Fri Apr 10 2026 10:29:39.
The average broker rating on Akums Drugs and Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Akums Drugs and Pharmaceuticals is 620.00 whereas the 52 wk low is 407.40
Akums Drugs and Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 21.82
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: -
Akums Drugs and Pharmaceuticals reported a net profit of 338.18 Cr in 2025.
The Mutual Fund Shareholding was 10.95% at the end of 31 Mar 2026.